Evidence map›Paper›PMID 34055054›Full record

ArticleExperimental and therapeutic medicine2021

Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes.

Zhaocheng Dong, Haoran Dai, Yu Gao, Zhendong Feng, Wenbin Liu, Fei Liu, Zihan Zhang, Fang Ma, Xinran Xie, Zebing Zhu and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Complement System, Aging, and Aging-Related Diseases.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Zhaocheng DongBeijing University of Chinese Medicine, Chaoyang, Beijing 100029, P.R. China.
Haoran DaiShunyi Branch, Beijing Traditional Chinese Medicine Hospital, Shunyi, Beijing 101300, P.R. China.
Yu GaoBeijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Dongcheng, Beijing 100010, P.R. China.
Zhendong FengBeijing Chinese Medicine Hospital, Pinggu Hospital, Pinggu, Beijing 101200, P.R. China.
Wenbin LiuBeijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Dongcheng, Beijing 100010, P.R. China.
Fei LiuBeijing University of Chinese Medicine, Chaoyang, Beijing 100029, P.R. China.
Zihan ZhangBeijing University of Chinese Medicine, Chaoyang, Beijing 100029, P.R. China.
Fang MaChina Academy of Traditional Chinese Medicine, Guanganmen Hospital, Xicheng, Beijing 100053, P.R. China.
Xinran XieBeijing Institute of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Dongcheng, Beijing 100010, P.R. China.
Zebing ZhuBeijing University of Chinese Medicine, Chaoyang, Beijing 100029, P.R. China.
Weijing LiuKey Laboratory of Chinese Internal Medicine of the Ministry of Education, Beijing University of Chinese Medicine Affiliated to Dongzhimen Hospital, Dongchen, Beijing 100700, P.R. China.
Baoli LiuBeijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Dongcheng, Beijing 100010, P.R. China.
Beijing University of Chinese Medicine · CNBeijing Hospital of Traditional Chinese Medicine · CNCapital Medical University · CNBeijing Anding Hospital · CNGuang’anmen Hospital · CNShunyi Hospital of Beijing Traditional Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In idiopathic membranous nephropathy, the complement membrane attack complex, more commonly referred to as complement 5b-9 (C5b-9), induces glomerular epithelial cell injury and proteinuria. C5b-9 can also activate numerous mechanisms that restrict or facilitate injury. Recent studies suggest that autophagy and the canonical Wnt signaling pathway serve an important role in repairing podocyte injury. However, the effect of C5b-9 on these pathways and the relationship between them remains unclear. The aim of the present study was to show the effect of C5b-9 on the Wnt/β-catenin signaling pathway and autophagy in podocytes

Indexed as

autophagycomplement 5b-9Dickkopf-related protein 1membranous nephropathypodocyteWnt/β-catenin signaling pathway

Identifiers

PMID34055054
PMCPMC8138266
OpenAlexW3163432313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.